FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3193637384> ?p ?o ?g. }

• W3193637384 endingPage "102280" @default.
• W3193637384 startingPage "102280" @default.
• W3193637384 abstract "The incidence of venous and arterial thromboembolic events in advanced cancer patients treated with immune checkpoint inhibitors (ICIs) has been sporadically reported. We performed a systematic review and meta-analysis to assess the rate of vascular events in patients with melanoma and non-small cell lung cancer (NSCLC) treated with ICIs. A systematic search of MEDLINE and EMBASE was performed to identify randomized clinical trials and prospective studies. The main outcomes were venous thromboembolism (VTE), stroke or systemic embolism (SE) and myocardial infarction (MI). Secondary outcomes were fatal VTE, fatal stroke or SE and fatal MI. Pooled proportions with 95% confidence intervals (CI) were calculated using random-effects models. A total of 59 trials, 25 in 5,578 patients with melanoma and 34 in 6,543 patients with NSCLC were included. In patients with melanoma, rates of VTE, stroke or SE and MI were 1.5% (95% CI 0.8–2.8), 1.7% (95% CI 0.8–3.7) and 0.4% (95% CI 0.2–0.9), respectively. In patients with NSCLC, corresponding rates were 1.9% (95% CI 1.2–3.2), 1.2% (95% CI 0.6–2.5), and 1.1% (95% CI 0.5–2.1), respectively. Rates of fatal VTE and MI were similar in melanoma and NSCLC patients. Rates of fatal stroke or SE were 1.9% (95% CI 0.4–9.5) and 0.7% (95% CI 0.2–2.3) in melanoma and NSCLC patients, respectively. Rates of VTE (3.1% vs. 1.1%) and myocardial infarction (3.4% Vs. 0.5%) were numerically higher in NSCLC patients treated with combined-ICIs vs mono-ICIs. Our study shows a not negligible rate of vascular events in patients with melanoma or NSCLC treated with ICIs." @default.
• W3193637384 created "2021-08-30" @default.
• W3193637384 creator A5010492722 @default.
• W3193637384 creator A5023893215 @default.
• W3193637384 creator A5054722205 @default.
• W3193637384 creator A5054783539 @default.
• W3193637384 creator A5064108429 @default.
• W3193637384 date "2021-11-01" @default.
• W3193637384 modified "2023-10-15" @default.
• W3193637384 title "Vascular events with immune checkpoint inhibitors in melanoma or non-small cell lung cancer: A systematic review and meta-analysis" @default.
• W3193637384 cites W1967084952 @default.
• W3193637384 cites W1990675339 @default.
• W3193637384 cites W2005501262 @default.
• W3193637384 cites W2038325530 @default.
• W3193637384 cites W2040851929 @default.
• W3193637384 cites W2081716782 @default.
• W3193637384 cites W2098414192 @default.
• W3193637384 cites W2103220202 @default.
• W3193637384 cites W2104347254 @default.
• W3193637384 cites W2106511606 @default.
• W3193637384 cites W2118982164 @default.
• W3193637384 cites W2123264723 @default.
• W3193637384 cites W2125435699 @default.
• W3193637384 cites W2136746908 @default.
• W3193637384 cites W2143772132 @default.
• W3193637384 cites W2147143600 @default.
• W3193637384 cites W2160834915 @default.
• W3193637384 cites W2161550811 @default.
• W3193637384 cites W2257916459 @default.
• W3193637384 cites W2347141054 @default.
• W3193637384 cites W2416791964 @default.
• W3193637384 cites W2529904548 @default.
• W3193637384 cites W2531269403 @default.
• W3193637384 cites W2551096297 @default.
• W3193637384 cites W2560704457 @default.
• W3193637384 cites W2587327379 @default.
• W3193637384 cites W2592369722 @default.
• W3193637384 cites W2599354912 @default.
• W3193637384 cites W2603690292 @default.
• W3193637384 cites W2635951006 @default.
• W3193637384 cites W2753065806 @default.
• W3193637384 cites W2766923414 @default.
• W3193637384 cites W2786816161 @default.
• W3193637384 cites W2790290963 @default.
• W3193637384 cites W2791290180 @default.
• W3193637384 cites W2791886669 @default.
• W3193637384 cites W2793007221 @default.
• W3193637384 cites W2795455773 @default.
• W3193637384 cites W2796582438 @default.
• W3193637384 cites W2803622877 @default.
• W3193637384 cites W2803640001 @default.
• W3193637384 cites W2805354595 @default.
• W3193637384 cites W2888298425 @default.
• W3193637384 cites W2891486030 @default.
• W3193637384 cites W2893602866 @default.
• W3193637384 cites W2893824814 @default.
• W3193637384 cites W2896600825 @default.
• W3193637384 cites W2898179628 @default.
• W3193637384 cites W2901290714 @default.
• W3193637384 cites W2911093128 @default.
• W3193637384 cites W2917037555 @default.
• W3193637384 cites W2925446385 @default.
• W3193637384 cites W2943437728 @default.
• W3193637384 cites W2945590213 @default.
• W3193637384 cites W2949375297 @default.
• W3193637384 cites W2952817507 @default.
• W3193637384 cites W2958083922 @default.
• W3193637384 cites W2963476376 @default.
• W3193637384 cites W2967645845 @default.
• W3193637384 cites W2976402945 @default.
• W3193637384 cites W2976744492 @default.
• W3193637384 cites W2991836312 @default.
• W3193637384 cites W2996270284 @default.
• W3193637384 cites W2997351648 @default.
• W3193637384 cites W3007099934 @default.
• W3193637384 cites W3008245730 @default.
• W3193637384 cites W3008374819 @default.
• W3193637384 cites W3012679786 @default.
• W3193637384 cites W3072782591 @default.
• W3193637384 cites W3091695757 @default.
• W3193637384 cites W3091938712 @default.
• W3193637384 cites W3092727194 @default.
• W3193637384 cites W3092857774 @default.
• W3193637384 cites W3104606679 @default.
• W3193637384 cites W3107870684 @default.
• W3193637384 cites W3107960404 @default.
• W3193637384 cites W3113132520 @default.
• W3193637384 cites W3118404775 @default.
• W3193637384 cites W3121907365 @default.
• W3193637384 cites W3124587416 @default.
• W3193637384 cites W3136390979 @default.
• W3193637384 cites W4294214797 @default.
• W3193637384 doi "https://doi.org/10.1016/j.ctrv.2021.102280" @default.
• W3193637384 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34438237" @default.
• W3193637384 hasPublicationYear "2021" @default.
• W3193637384 type Work @default.
• W3193637384 sameAs 3193637384 @default.
• W3193637384 citedByCount "8" @default.

• next